Insmed Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 1690.15, 2769.62, 3821.81, 4939.13, 6172.47 ], "ebit_estimate": [ -553.36, 198.72, 952.06, 1771.47, 2678.62 ], "ebitda_estimate": [ -569.12, 222.22, 883.92, 1667.68, null ], "net_income_estimate": [ -609.85, 67.45, 843.55, 1664.88, 2444.73 ], "per_share_eps_estimate": [ -2.71, 0.52, 3.69, 7.02, 10.07 ], "eps_nri_estimate": [ -2.74, 0.34, 3.6, 7.02, 10.07 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.34, 2.85, 6.53, null, null ], "pretax_income_estimate": [ -607.99, 106.01, 902.76, 1788.89, 2721.23 ], "operating_cash_flow_per_share_estimate": [ -2.7, 1.58, 2.76, null, null ], "roa_estimate": [ -25.3, 14.8, 33.3, null, null ], "roe_estimate": [ -121.47, 20.82, 40.01, null, null ], "gross_margin_estimate": [ 83, 83.15, 82.39, 82.1, 82.28 ], "operating_cash_flow_estimate": [ -581.05, 341.15, 593.61, null, null ], "pettm_estimate": [ 0, 222.76, 31.3, 16.46, 11.49 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "82.51", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 82.51, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 1.39, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 389.55, 463.3, 529.72, 542.09, 611.03, 674.28, 724.76, 769.43 ], "ebit_estimate": [ -161.19, -120.18, -98.63, -23.25, 16.2, 32.75, 47.05, null ], "ebitda_estimate": [ -162.6, -135.34, -148.1, null, null, null, null, null ], "net_income_estimate": [ -176.06, -135.45, -114.27, -30.8, 7.45, 30, 43.45, null ], "per_share_eps_estimate": [ -0.81, -0.63, -0.52, -0.04, 0.08, 0.2, 0.32, 0.22 ], "eps_nri_estimate": [ -0.81, -0.63, -0.55, -0.11, 0.06, 0.17, 0.28, 0.48 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -177.02, -133.66, -112.74, -30.8, 7.45, 30, 45.45, null ], "operating_cash_flow_per_share_estimate": [ -1.09, -1.14, -1.31, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 83.21, 83.13, 80.75, null, null, null, null, null ], "operating_cash_flow_estimate": [ -234.86, -245.63, -282.26, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 203.18, 139.46, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "82.51", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 82.51, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 1.39, "future_operating_cash_flow_per_share_estimate_growth": null }